Group One Trading
VOR icon

Group One Trading’s Vor Biopharma VOR Stock Holding History

Group One Trading’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Buy
+9,065
New +$128K ﹤0.01% 4295
2025
Q2 		– Sell
-34
Closed -$300 – 8721
2025
Q1 		$486 Sell
34
-87
-72% -$2.09K ﹤0.01% 7284
2024
Q4 		$2.69K Buy
+121
New +$2K ﹤0.01% 6644
2024
Q3 		– Sell
-11
Closed -$201 – 7425
2024
Q2 		$229 Sell
11
-160
-94% -$5.17K ﹤0.01% 6512
2024
Q1 		$8.13K Sell
171
-329
-66% -$14.4K ﹤0.01% 5976
2023
Q4 		$22.5K Buy
+500
New +$20.6K ﹤0.01% 5656

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's VOR Position: Q1 2026 in Review

Group One Trading opened a new position in Vor Biopharma (VOR) in Q1 2026: 9,065 shares worth $162K. The stake represents ﹤0.01% of the portfolio and ranks #4295 among its holdings. This is a return to the name: Group One Trading previously reported a position in VOR as recently as Q1 2025.

Group One Trading first reported a position in VOR in Q4 2023 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Group One Trading held 9,065 shares of Vor Biopharma worth $162K as of Q1 2026.
  • Vor Biopharma was a new Group One Trading position in Q1 2026.
  • Vor Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4295 holding.
  • Group One Trading first reported a position in Vor Biopharma in Q4 2023 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.